Please note: The information displayed on this page might be outdated.
Incysus Therapeutics: Operator of a biotechnology company intended to develop immune-based therapies for the treatment of cancer. The company's services focus on utilizing genetically modified gamma-delta T cells across a Drug Resistance Immunotherapy (DRI) platform that addresses the challenges faced while targeting cold, low mutation cancers, enabling the targeting of malignant cells and potentially more effective treatments for patients with difficult-to-treat solid tumor cancers.
Sector/Industry:
Healthcare
Characteristics:
Based in...
US - Middle Atlantic
Disease Space
Oncology
Listing
Private
Therapeutic Modalities
Cell Therapy, Gene Therapy
Website:
Address:
79 Madison Avenue
New York, NY 10016
United States

Company Participants at Solebury Trout CEO & Investor Ski Conference 2020

  • William T. Ho, CEO